Ni, L., Zhang, W., Chen, Y., Leng, W., Gou, H., Hu, J., & Qiu, M. (2021). A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas. Medicine (Baltimore).

Ni, Lu, Weihan Zhang, Ye Chen, Weibing Leng, Hongfeng Gou, Jiankun Hu, a Meng Qiu. "A Randomized Phase II Trial Comparing Capecitabine With Oxaliplatin or Docetaxel As First-line Treatment in Advanced Gastric and Gastroesophageal Adenocarcinomas." Medicine (Baltimore) 2021.

Ni, Lu, et al. "A Randomized Phase II Trial Comparing Capecitabine With Oxaliplatin or Docetaxel As First-line Treatment in Advanced Gastric and Gastroesophageal Adenocarcinomas." Medicine (Baltimore) 2021.